Takashi Iuni (Takashi Inui)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 6

Top Topics

Molecular Dynamics Simulations

Atopic Dermatitis

Top Venues

The FEBS journal

Molecular pharmaceutics

NPJ science of food

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Yuya Miyamoto, Masatoshi Nakatsuji, Takuya Yoshida, Tadayasu Ohkubo, Takashi Iuni
Structural and interaction analysis of human lipocalin-type prostaglandin D synthase with the poorly water-soluble drug NBQX. The FEBS journal (2023)
Osamu Ishibashi, Mika Hayashi, Aya Horikawa, Hitoshi Owada, Ryotaro Miyamoto, Naoya Mizukami, Takashi Iuni
The Role of miR-217-5p in the Puromycin Aminonucleoside-Induced Morphological Change of Podocytes. Non-coding RNA 8 (3) (2022)
Naoki Harada, Mai Okuyama, Yoshiaki Teraoka, Yumi Arahori, Yoh Shinmori, Hiroko Horiuchi, Paula B Luis, Akil I Joseph, Tomoya Kitakaze, Shigenobu Matsumura, Tohru Hira, Norio Yamamoto, Takashi Iuni, Naoki Goshima, Claus Schneider, Hiroshi Inui, Ryoichi Yamaji
Identification of G protein-coupled receptor 55 (GPR55) as a target of curcumin. NPJ science of food 6 (1) (2022)
Masatoshi Nakatsuji, Keisuke Sugiura, Keisuke Suda, Michiko Sakurai, Miki Ubatani, Haruka Muroya, Rina Okubo, Ryo Noguchi, Yoichi Kamata, Yuma Fukutomi, Osamu Ishibashi, Shigenori Nishimura, Takashi Iuni
Structure-based prediction of the IgE epitopes of the major dog allergen Can f 1. The FEBS journal (2021)
Akira Imamura, Tetsuya Okada, Hikaru Mase, Takuya Otani, Tomoka Kobayashi, Manatsu Tamura, Bruno Kilunga Kubata, Katsuaki Inoue, Robert P Rambo, Susumu Uchiyama, Kentaro Ishii, Shigenori Nishimura, Takashi Iuni
Allosteric regulation accompanied by oligomeric state changes of Trypanosoma brucei GMP reductase through cystathionine-β-synthase domain. Nature communications 11 (1) (2020)
Yoshiaki Teraoka, Satoshi Kume, Yuxi Lin, Shogo Atsuji, Takashi Iuni
Comprehensive Evaluation of the Binding of Lipocalin-Type Prostaglandin D Synthase to Poorly Water-Soluble Drugs. Molecular pharmaceutics 14 (10) (2017)